Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adel Youssef

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Scientific Reports|January 17, 2025
Curcumin mimics of potential chemoprevention with NQO1 induction propertiesDalia R Aboshouk, Ahmed R Hamed, Siva S Panda, et al.
Annals of Surgical Oncology|October 7, 2004
Upper extremity reconstruction following resection of soft tissue sarcomas: a functional outcomes analysisJohn Y Kim, Adel Youssef, Vairavan Subramanian, et al.
Ophthalmic Plastic and Reconstructive Surgery|January 31, 2004
Outcomes in patients with adenoid cystic carcinoma of the lacrimal glandBita Esmaeli, M Amir Ahmadi, Adel Youssef, et al.
Plastic and Reconstructive Surgery|January 13, 2006
Determining the optimal approach to breast reconstruction after partial mastectomySteven J Kronowitz, Jules A Feledy, Kelly K Hunt, et al.
Annals of Surgical Oncology|June 19, 2007
Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancerPatricia A Parker, Adel Youssef, Sue Walker, et al.
RSC Advances|May 6, 2022
Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2'-pyrrolidine-3',3''-pyrrolidines]M Adel Youssef, Siva S Panda, Riham A El-Shiekh, et al.
Plastic and Reconstructive Surgery|December 10, 2003
Optimizing autologous breast reconstruction in thin patientsSteven J Kronowitz, Geoffrey L Robb, Adel Youssef, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53-MDM2 ModulationAdel S Girgis, Yujun Zhao, Angel Nkosi, et al.
Scientific Reports|January 3, 2025
Design and synthesis of antiproliferative 2-oxoindolin-3-ylidenes incorporating urea function with potential VEGFR-2 inhibitory propertiesDalia R Aboshouk, M Adel Youssef, Siva S Panda, et al.
Journal of Epidemiology and Global Health|July 7, 2025
Prevalence and Patterns of Skin Diseases among School Children in Egypt: A National Cross-sectional StudyAzza Gaber Antar Farag, Zeinab Abdelaziz Kasemy, Ahmed Elsayed Elnemr, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Scientific Reports|January 17, 2025
Curcumin mimics of potential chemoprevention with NQO1 induction propertiesDalia R Aboshouk, Ahmed R Hamed, Siva S Panda, et al.
Annals of Surgical Oncology|October 7, 2004
Upper extremity reconstruction following resection of soft tissue sarcomas: a functional outcomes analysisJohn Y Kim, Adel Youssef, Vairavan Subramanian, et al.
Ophthalmic Plastic and Reconstructive Surgery|January 31, 2004
Outcomes in patients with adenoid cystic carcinoma of the lacrimal glandBita Esmaeli, M Amir Ahmadi, Adel Youssef, et al.
Plastic and Reconstructive Surgery|January 13, 2006
Determining the optimal approach to breast reconstruction after partial mastectomySteven J Kronowitz, Jules A Feledy, Kelly K Hunt, et al.
Annals of Surgical Oncology|June 19, 2007
Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancerPatricia A Parker, Adel Youssef, Sue Walker, et al.
RSC Advances|May 6, 2022
Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2'-pyrrolidine-3',3''-pyrrolidines]M Adel Youssef, Siva S Panda, Riham A El-Shiekh, et al.
Plastic and Reconstructive Surgery|December 10, 2003
Optimizing autologous breast reconstruction in thin patientsSteven J Kronowitz, Geoffrey L Robb, Adel Youssef, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53-MDM2 ModulationAdel S Girgis, Yujun Zhao, Angel Nkosi, et al.
Scientific Reports|January 3, 2025
Design and synthesis of antiproliferative 2-oxoindolin-3-ylidenes incorporating urea function with potential VEGFR-2 inhibitory propertiesDalia R Aboshouk, M Adel Youssef, Siva S Panda, et al.
Journal of Epidemiology and Global Health|July 7, 2025
Prevalence and Patterns of Skin Diseases among School Children in Egypt: A National Cross-sectional StudyAzza Gaber Antar Farag, Zeinab Abdelaziz Kasemy, Ahmed Elsayed Elnemr, et al.
Pageof 4